Oil rises on surprise U.S. crude drawdown, prospect of OPEC action
October 23, 2019
Facebook’s Zuckerberg grilled in U.S. Congress on digital currency, privacy, elections
October 23, 2019

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar

Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.

Powered by WPeMatico